Target intelligence / Profile preview

Focal adhesion signaling components (FA signaling)

Target
FA signaling
Molecular classification
Enzyme, Receptor, Adaptor protein, Cytoskeletal protein
01

Overview

Focal adhesion signaling components represent a complex network of proteins that facilitate communication between the extracellular matrix (ECM) and the cell's interior (Parsons et al., 2010). This signaling hub is initiated by the clustering of integrin receptors upon ECM binding, which subsequently recruits structural proteins like vinculin and talin, as well as signaling enzymes such as Focal Adhesion Kinase (FAK) and Src (Hynes, 2002). These components integrate mechanical and chemical signals to regulate essential cellular behaviors, including migration, survival, and cell cycle progression through the activation of downstream cascades like PI3K/Akt and MAPK/ERK (Sulzmaier et al., 2014). In the context of disease, particularly malignancy, dysregulation of focal adhesion signaling is a hallmark of the epithelial-to-mesenchymal transition (EMT), driving tumor cell invasion and metastasis (Tai et al., 2015). Therapeutic strategies often focus on inhibiting specific enzymatic components like FAK or Src to suppress these pro-tumorigenic signals and overcome chemoresistance, with several inhibitors such as defactinib and dasatinib undergoing clinical evaluation (Infante et al., 2015).

Other names
Focal adhesion pathwayIntegrin-mediated signalingFocal adhesion complexCell-matrix adhesion signaling
02

Mechanism of action

Inhibition of Focal Adhesion Kinase (FAK) autophosphorylation at Tyr397, inhibition of Src family kinase activity, and competitive blockade of integrin-extracellular matrix ligand binding to disrupt downstream PI3K/Akt and MAPK/ERK signaling pathways.

03

Biological functions

Cell adhesionCell migrationSignal transductionCell proliferationCell survivalMechanotransduction
04

Disease associations

CancerFibrosisCardiovascular diseaseInflammationMetastatic progression
05

Safety considerations

Impaired wound healingGastrointestinal toxicity (nausea, diarrhea)Pleural effusion (associated with Src inhibitors)Potential for systemic disruption of normal cell-matrix interactionsFatigue
06

Interacting drugs

Defactinib

5 more in the full profile.

07

Biomarkers

Phospho-FAK (Tyr397)Integrin alpha-V expressionPaxillin phosphorylationSrc kinase activity levels

Beyond the preview

Go deeper on Focal adhesion signaling components (FA signaling).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Focal adhesion signaling components (FA signaling).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call